Supreme Court Denies Dershowitz Defamation Suit Against CNN
The Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
20,321 articlesThe Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
With $850,000 saved at 59, a couple can expect about $2,600-$2,800 a month in early retirement from portfolios, befor...
Markets confront a paradox: AI’s potential is immense, but real-world adoption is uneven. Household budgets and inves...
A major market moment is shaping up as Dan Ives weighs in on SpaceX’s potential public debut. This article breaks dow...
Short sellers now hold about 31% of SpaceX’s tradable float, a level that could ignite a volatile squeeze unless the ...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
Greg Abel leads Berkshire Hathaway as the company holds a record cash pile. This in-depth guide explains what that me...
Legendary investor Michael Burry has taken a direct short against Micron Technology, challenging the view that AI-dri...
The yen is on a renewed slide, with policymakers juggling debt, inflation, and global rate moves as quietly crashing ...
Tesla is quietly scaling its energy storage and grid modernization business, a growth engine many investors overlook ...
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Two Vanguard growth-focused funds sit on opposite ends of the market cap spectrum. This guide weighs small-cap opport...